Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

Molecular profiles and clinical outcome of stage UICC II colon cancer patients.

Gröne J, Lenze D, Jurinovic V, Hummel M, Seidel H, Leder G, Beckmann G, Sommer A, Grützmann R, Pilarsky C, Mansmann U, Buhr HJ, Stein H, Hummel M.

Int J Colorectal Dis. 2011 Jul;26(7):847-58. doi: 10.1007/s00384-011-1176-x. Epub 2011 Apr 5.

PMID:
21465190
[PubMed - indexed for MEDLINE]
2.

Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J, McLeod HL, Atkins D.

J Clin Oncol. 2004 May 1;22(9):1564-71. Epub 2004 Mar 29.

PMID:
15051756
[PubMed - indexed for MEDLINE]
Free Article
3.

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.

Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D, Ayadi M, Kirzin S, Chazal M, Fléjou JF, Benchimol D, Berger A, Lagarde A, Pencreach E, Piard F, Elias D, Parc Y, Olschwang S, Milano G, Laurent-Puig P, Boige V.

PLoS Med. 2013;10(5):e1001453. doi: 10.1371/journal.pmed.1001453. Epub 2013 May 21.

PMID:
23700391
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer.

Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, Merrie AE, van Rij A, Yoon HS, McCall JL, Siewert JR, Holzmann B, Reeve AE.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):498-507.

PMID:
17255271
[PubMed - indexed for MEDLINE]
Free Article
5.

Gene expression profiles in stages II and III colon cancers: application of a 128-gene signature.

Thorsteinsson M, Kirkeby LT, Hansen R, Lund LR, Sørensen LT, Gerds TA, Jess P, Olsen J.

Int J Colorectal Dis. 2012 Dec;27(12):1579-86. doi: 10.1007/s00384-012-1517-4. Epub 2012 Jun 19.

PMID:
22710688
[PubMed - indexed for MEDLINE]
6.

Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients.

Barrier A, Boelle PY, Lemoine A, Tse C, Brault D, Chiappini F, Lacaine F, Houry S, Huguier M, Flahault A, Dudoit S.

Dis Colon Rectum. 2005 Dec;48(12):2238-48.

PMID:
16228831
[PubMed - indexed for MEDLINE]
7.

Stage II colon cancer prognosis prediction by tumor gene expression profiling.

Barrier A, Boelle PY, Roser F, Gregg J, Tse C, Brault D, Lacaine F, Houry S, Huguier M, Franc B, Flahault A, Lemoine A, Dudoit S.

J Clin Oncol. 2006 Oct 10;24(29):4685-91. Epub 2006 Sep 11.

PMID:
16966692
[PubMed - indexed for MEDLINE]
Free Article
8.

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

Zentralbl Gynakol. 2006 Apr;128(2):76-81.

PMID:
16673249
[PubMed - indexed for MEDLINE]
9.

Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling.

Barrier A, Roser F, Boëlle PY, Franc B, Tse C, Brault D, Lacaine F, Houry S, Callard P, Penna C, Debuire B, Flahault A, Dudoit S, Lemoine A.

Oncogene. 2007 Apr 19;26(18):2642-8. Epub 2006 Oct 9.

PMID:
17043639
[PubMed - indexed for MEDLINE]
10.

Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence.

Belt EJ, Fijneman RJ, van den Berg EG, Bril H, Delis-van Diemen PM, Tijssen M, van Essen HF, de Lange-de Klerk ES, Beliën JA, Stockmann HB, Meijer S, Meijer GA.

Eur J Cancer. 2011 Aug;47(12):1837-45. doi: 10.1016/j.ejca.2011.04.025. Epub 2011 May 27.

PMID:
21621406
[PubMed - indexed for MEDLINE]
Free Article
11.

A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.

Chanrion M, Negre V, Fontaine H, Salvetat N, Bibeau F, Mac Grogan G, Mauriac L, Katsaros D, Molina F, Theillet C, Darbon JM.

Clin Cancer Res. 2008 Mar 15;14(6):1744-52. doi: 10.1158/1078-0432.CCR-07-1833.

PMID:
18347175
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.

Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA.

Gut. 2012 Nov;61(11):1560-7. Epub 2012 Jan 2.

PMID:
22213796
[PubMed - indexed for MEDLINE]
13.

Cdc2 as prognostic marker in stage UICC II colon carcinomas.

Meyer A, Merkel S, Brückl W, Schellerer V, Schildberg C, Campean V, Hohenberger W, Croner RS.

Eur J Cancer. 2009 May;45(8):1466-73. doi: 10.1016/j.ejca.2009.01.010. Epub 2009 Feb 14.

PMID:
19223178
[PubMed - indexed for MEDLINE]
14.

Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.

Kennedy RD, Bylesjo M, Kerr P, Davison T, Black JM, Kay EW, Holt RJ, Proutski V, Ahdesmaki M, Farztdinov V, Goffard N, Hey P, McDyer F, Mulligan K, Mussen J, O'Brien E, Oliver G, Walker SM, Mulligan JM, Wilson C, Winter A, O'Donoghue D, Mulcahy H, O'Sullivan J, Sheahan K, Hyland J, Dhir R, Bathe OF, Winqvist O, Manne U, Shanmugam C, Ramaswamy S, Leon EJ, Smith WI Jr, McDermott U, Wilson RH, Longley D, Marshall J, Cummins R, Sargent DJ, Johnston PG, Harkin DP.

J Clin Oncol. 2011 Dec 10;29(35):4620-6. doi: 10.1200/JCO.2011.35.4498. Epub 2011 Nov 7.

PMID:
22067406
[PubMed - indexed for MEDLINE]
Free Article
15.

Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer.

Maak M, Simon I, Nitsche U, Roepman P, Snel M, Glas AM, Schuster T, Keller G, Zeestraten E, Goossens I, Janssen KP, Friess H, Rosenberg R.

Ann Surg. 2013 Jun;257(6):1053-8. doi: 10.1097/SLA.0b013e31827c1180.

PMID:
23295318
[PubMed - indexed for MEDLINE]
16.

Colon cancer prognosis prediction by gene expression profiling.

Barrier A, Lemoine A, Boelle PY, Tse C, Brault D, Chiappini F, Breittschneider J, Lacaine F, Houry S, Huguier M, Van der Laan MJ, Speed T, Debuire B, Flahault A, Dudoit S.

Oncogene. 2005 Sep 8;24(40):6155-64.

PMID:
16091735
[PubMed - indexed for MEDLINE]
17.

Tumor microRNA-29a expression and the risk of recurrence in stage II colon cancer.

Weissmann-Brenner A, Kushnir M, Lithwick Yanai G, Aharonov R, Gibori H, Purim O, Kundel Y, Morgenstern S, Halperin M, Niv Y, Brenner B.

Int J Oncol. 2012 Jun;40(6):2097-103. doi: 10.3892/ijo.2012.1403. Epub 2012 Mar 16.

PMID:
22426940
[PubMed - indexed for MEDLINE]
18.

Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.

Lanza G, Gafà R, Santini A, Maestri I, Dubini A, Gilli G, Cavazzini L.

Cancer. 1998 Jan 1;82(1):49-59.

PMID:
9428479
[PubMed - indexed for MEDLINE]
19.

A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients.

Bandrés E, Malumbres R, Cubedo E, Honorato B, Zarate R, Labarga A, Gabisu U, Sola JJ, García-Foncillas J.

Oncol Rep. 2007 May;17(5):1089-94.

PMID:
17390049
[PubMed - indexed for MEDLINE]
20.

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.

Jiang Y, Casey G, Lavery IC, Zhang Y, Talantov D, Martin-McGreevy M, Skacel M, Manilich E, Mazumder A, Atkins D, Delaney CP, Wang Y.

J Mol Diagn. 2008 Jul;10(4):346-54. doi: 10.2353/jmoldx.2008.080011. Epub 2008 Jun 13.

PMID:
18556775
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk